Validation of the dual-table autoradiographic method to quantify two sequential rCBFs in a single SPET session with N-isopropyl-[ 123I]p-iodoamphetamine

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue 7, 2003, Pages 943-950

  Nishizawa, Sadahiko ^a,d   Iida, Hidehiro ^b   Tsuchida, Tatsuro ^a   Ito, Harumi ^a   Konishi, Junji ^c   Yonekura, Yoshiharu ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d Hamamatsu Medical Photonics Foundation   (Japan)

Author keywords

Cerebrovascular reserve capacity; N Isopropyl 123I p iodoamphetamine; Regional cerebral blood flow; Single photon emission tomography

Indexed keywords

ACETAZOLAMIDE; IOFETAMINE I 123;

ADULT; AREA UNDER THE CURVE; ARTERIAL BLOOD; ARTICLE; AUTORADIOGRAPHY; BLOOD SAMPLING; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; CALIBRATION; CEREBROVASCULAR RESERVE CAPACITY; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG DISTRIBUTION; DUAL TABLE AUTORADIOGRAPHIC METHOD; HUMAN; INTERMETHOD COMPARISON; NONLINEAR SYSTEM; QUANTITATIVE ANALYSIS; RADIOACTIVITY; RELIABILITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VALIDATION PROCESS;

ACETAZOLAMIDE; ALGORITHMS; AUTORADIOGRAPHY; BRAIN; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; COMPUTER SIMULATION; HUMANS; IOFETAMINE; MODELS, CARDIOVASCULAR; RADIOISOTOPE DILUTION TECHNIQUE; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0042192118     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1180-7     Document Type: Article

References (21)

1. Yamauchi H, Fukuyama H, Nagahama Y, Nabatame H, Nakamura K, Yamamoto Y, Yonekura Y, Konishi J, Kimura J. Evidence of misery perfusion and risk for recurrent stroke in major cerebral arterial occlusive diseases from PET. J Neurol Neurosurg Psychiatry 1996; 61:18-25.
2. Grubb RL Jr, Derdeyn CP, Fritsch SM, Carpenter DA, Yundt KD, Videen TO, Spitznagel EL, Powers WJ. Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA 1998; 280:1055-1060.
3. Yamauchi H, Fukuyama H, Nagahama Y, Nabatame H, Ueno M, Nishizawa S, Konishi J, Shio H. Significance of increased oxygen extraction fraction in five-year prognosis of major cerebral arterial occlusive diseases. J Nucl Med 1999; 40:1992-1998.
4. Kuroda S, Houkin K, Kamiyama H, Mitsumori K, Iwasaki Y, Abe H. Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? Stroke 2001; 32:2110-2116.
5. Greenberg JH, Kushner M, Rango M, Alavi A, Reivich M. Validation studies of iodine-123-iodoamphetamine as a cerebral blood flow tracer using emission tomography. J Nucl Med 1990; 31:1364-1369.
6. Yokoi T, Iida H, Itoh H, Kanno I. A new graphic plot analysis for cerebral blood flow and partition coefficient with iodine-123-iodoamphetamine and dynamic SPECT validation studies using oxygen-15-water and PET. J Nucl Med 1993; 34:498-505.
7. Yonekura Y, Nishizawa S, Mukai T, Iwasaki Y, Fukuyama H, Ishikawa M, Tamaki N, Konishi J. Functional mapping of flow and back-diffusion rate of N-isopropyl-p-iodoamphetamine in human brain. J Nucl Med 1993; 34:839-844.
8. Iida H, Itoh H, Nakazawa M, Hatazawa J, Nishimura H, Onishi Y, Uemura K. Quantitative mapping of regional cerebral blood flow using iodine-123-IMP and SPET. J Nucl Med 1994; 35:2019-2030.
9. 123I-IMP single photon emission computed tomography in patients with major cerebral artery occlusive disease: correlation with positron emission tomography parameters. J Cereb Blood Flow Metab 1994; 14:763-770.
10. Nariai T, Suzuki R, Hirakawa K, Maehara T, Ishii K, Senda M. Vascular reserve in chronic cerebral ischemia measured by the acetazolamide challenge test: comparison with positron emission tomography. Am J Neuroradiol 1995; 16:563-570.
11. Nishizawa S, Yonekura Y, Tanaka F, Fujita T, Tsuchimochi S, Ishizu K, Okazawa H, Tamaki N, Konishi J. Evaluation of a double-injection method for sequential measurement of cerebral blood flow with iodine-123-iodoamphetamine. J Nucl Med 1995; 36:1339-1345.
12. 123I]iodoamphetamine and single photon emission computed tomography. J Cereb Blood Flow Metab 1996; 16:781-793.
13. Hatazawa J, Iida H, Shimosegawa E, Sato T, Murakami M, Miura Y. Regional cerebral blood flow measurement with iodine-123-IMP autoradiography: normal values, reproducibility and sensitivity to hypoperfusion. J Nucl Med 1997; 38:1102-1108.
14. Kuhl DE, Bario JR, Huang SC. Quantifying local cerebral blood flow by N-isopropyl-p(I-123)iodoamphetamine tomography. J Nucl Med 1982; 23:196-203.
15. 123I]p-iodoamphetamine: single-pass brain uptake and washout; binding to brain synaptosomes; and localization in dog and monkey brain. J Nucl Med 1980; 21:947-952.
16. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; i:307-310.
17. Bland JM, Altman DG. A note on the use of the intraclass correlation coefficient in the evaluation of agreement between two methods of measurement. Comput Biol Med 1990; 20:337-340.
18. Matsuda H, Seki H, Sumiya H. Quantitative cerebral blood flow measurements using N-isopropyl-(iodine-123)p-iodoamphetamine and single photon emission computed tomography with rotating gamma camera. Am J Physiol Imaging 1986; 1:186-194.
19. Murase K, Tanada S, Mogami H. Validity of microsphere model in cerebral blood flow measurement using N-isopropyl-p-(I-123) iodoamphetamine. Med Phys 1990; 17:79-83.
20. Ueno M, Nishizawa S, Toyoda H, Shimono T, Miyamoto S, Hashimoto N, Konishi J. Assessment of cerebral hemodynamics before and after revascularization in patients with occlusive cerebrovascular disease by means of quantitative IMP-SPECT with double-injection protocol. Ann Nucl Med 2001; 15:209-215.
21. Okubo M, Odano I, Takahashi M. A comparative study of simple methods to measure regional cerebral blood flow using iodine-123-IMP SPECT. J Nucl Med 1997; 38:597-601.